Posted by Admin | Posted in Medical Lawyers | Posted on 09-04-2009
SILVER SPRING, Md. (EGMN) The Food and Drug Administrations Psychopharmacologic Drugs Advisory Committee voted on April 8 that quetiapine fumarate is safe as an adjunctive therapy for major depressive disorder and generalized anxiety disorder, but not as a stand-alone treatment for GAD and only in certain instances as a stand-alone therapy for MDD.
Posted by Admin | Posted in Medical Lawyers | Posted on 04-04-2009
SILVER SPRING, Md. (EGMN) The majority of a federal advisory panel has agreed that the available cardiovascular safety data on the antidiabetic drug liraglutide were adequate to rule out an unacceptable increase in cardiovascular risk when compared to other diabetes drugs.
Posted by Admin | Posted in Medical Lawyers | Posted on 03-04-2009
Moxifloxacin increased the proportion of tuberculosis cultures converting to negative at 8 weeks by nearly 20% when added to the usual first-line triple-drug treatment regimen in a single-center, phase II trial in Brazil.
Posted by Admin | Posted in Medical Lawyers | Posted on 01-04-2009
SILVER SPRING, Md. (EGMN)The results of two phase II studies support accelerated approval of the anti-angiogenesis drug bevacizumab as a treatment for refractory glioblastoma multiforme, a federal advisory panel unanimously agreed at a March 31 meeting.